Despite the well-established knowledge of solanine's inhibitory effects on multiple signaling pathways such as NF-κB, ERK1/2, AKT and STAT1, its precise effect on gliomas through STAT1 remains uncertain [57]. This evidence concerns the gene MAPK3 and central nervous system cancer.